Eduardo Montero Solís

Association of periodontitis and COVID-19

  • Degree in Dentistry. Universidad Complutense de Madrid (UCM)
  • Master of Science in Periodontology and Implant Dentistry (UCM)
  • Certificate of Completion of Specialised Training (CCST) in Periodontology by the European Federation of Periodontology (EFP)
  • PhD wih International Mention (UCM)
  • Postgraduate Diploma in Statistics in Health Sciences and Master in Research Methodology. University Autonoma of Barcelona (UAB)
  • Associate Professor of Periodontology. Faculty of Dentistry (UCM)
  • Member of the Working Group of the Spanish Society of Periodontology (SEPA) and the Spanish Society of Diabetes (SED)
  • Member of the Experts Council of the Osteology Foundation
  • Member of the Education Committee of the European Association of Osseointegration (EAO)
  • Clinical practice limited to periodontology and implant dentistry in Madrid, Spain

Nationality: Spain

Scientific areas: On Our Agenda

4 of november, from 09h35 until 10h10

Auditorium C

Conference summary

The systemic inflammation that characterizes both the COVID-19 and periodontitis may be a potential mediator upon the association between these diseases. Specifically, it has been proposed that the severity of the COVID-19 infection, represented by the need of assisted ventilation, admission to intensive care units (ICUs) or even death, may be associated with the severity of the periodontal destruction.

Furthermore, main biomarkers of systemic inflammation, such as the C-reactive protein, or even other biomarkers associated with atherosclerosis (e.g. IL-6, fibrinogen, D-dimer, etc.) seem to be particularly elevated among patients with COVID-19 and bone loss >15% of the root length.

If a causal link between periodontitis and increased rates of adverse events in COVID-19 patients is established, then periodontal care may become crucial on the care of these patients.

 

Scientific sponsor